Category: Growing
-
Cresco Labs’ (CL.C) no-premium acquisition offer of Origin House (OH.C) is… alright
This morning, Chicago-based Cresco Labs (CL.C) announced it would be acquiring Origin House (OH.C) (formerly CannaRoyalty) in an all-stock deal worth CAN$1.1 billion. The offer comes in at CAN$12.68 per Origin House share. Origin House closed Friday at $12.05, which leaves the premium on the deal being less than amazing. In fact, the stock has…
-
Cannabis Life Sciences (CSE:CLSH.U): The US multi state operator value pick
I love it when the market is busy fighting over inflated market caps, because I’m a Moneyball guy. I like value, and while a lot of money has moved toward Canadian cannabis operators in recent years, the size of the market down south is only now starting to become clear. There’s still some value floating…
-
Supreme Cannabis (FIRE.T) doubles production capacity
In Rock & Roll, the 3-chord song (tonic, subdominant, and dominant) – sometimes called the “I, IV and V” – is considered the most elegant structure. If Supreme Cannabis was a Rock & Roll song, here are its 3 chords: l – grow premium weed lV – brand premium weed V– sell premium weed On…
-
![Westleaf (WL.V) brings prairie focus, first nations connections, novel ideas]()
Westleaf (WL.V) brings prairie focus, first nations connections, novel ideas
I first heard about the Prairie Records cannabis retail business model mid last year. And my first thought upon seeing it was, this will never be allowed. Basically, instead of keeping everything behind glass and having consumers guess as to what weed they’re looking at and what it will do, Westleaf’s retail model is to…
-
Cannara Biotech (LOVE.C) makes MedMen look like a charitable institution
Cannara Biotech (LOVE.C) is a pig. I mean, okay. Pigs are actually kind of cool, they’re smart and bacon tastes good and they like a tummy rub, so Cannara is not actually a pig. But it is a trap for your money, and you should ideally not play with money traps because their sole purpose is,…
-
Aphria (APHA.T) ‘Special Committee’ confirms short seller conflict of interest allegations
Several months ago, Aphria (APHA.T) lost a good chunk of its worth when short sellers accused the company executive and board of (in a nutshell) feathering their own nests by agreeing to acquire properties from themselves, for much inflated prices. Today, after a ridiculously long wait which involved the CEO stepping sideways from his position…
-
Weed company house cleaning: Bonify loses its LP license but grownups are emerging
“We couldn’t be happier to let registered patients know that they can now buy direct from Bonify, a company that truly puts its customers at the core of everything we do,” said company CEO and President Dalbir Bains, back in June 2018, when the company got its Health Canada cannabis sales license. “With the Canadian…
-
SLANG Worldwide (SLNG.C): I have seen the future of cannabis, and this is it
That’s a pretty salesy headline, huh? I mean, I couldn’t have given a higher five to a company in an ultra competitive space with billions in valuations flying around the world than to say, ‘this is the future.’ What I’m suggesting is, one company is on the ultra right path, and not many others are.…
-
TGOD vs Wildflower: Underplaying your hand as opposed to overplaying it
Two news releases wafted past me yesterday that caused me to dig deeper than the words written on the page. This sometimes happens out of necessity – a company has to release news about a topic but can’t go into detail yet, or has bad news they don’t particularly want to run a highlighter over.…
-
Pure Global Cannabis (PURE.V) is up nearly double in a week – and still dirt cheap
When I write about Pure Global (PURE.V), people get confused because a) they’re always down, and b) they’re not a client company. They should be a running joke, right? Like an Instadose or a Namaste (N.V). Well if you bought in when I did, that’s even truer. It hit the markets on opening day around…
